TFO Wealth Partners’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-15
Closed -$1.1K 335
2024
Q1
$1.1K Sell
15
-39
-72% -$3K ﹤0.01% 151
2023
Q4
$4.37K Hold
54
﹤0.01% 114
2023
Q3
$4.16K Buy
54
+39
+260% +$3K ﹤0.01% 180
2023
Q2
$1.16K Hold
15
﹤0.01% 199
2023
Q1
$1.25K Buy
15
+14
+1,400% +$1.16K ﹤0.01% 158
2022
Q4
$46 Buy
+1
New +$79 ﹤0.01% 863
2022
Q3
Sell
-456
Closed -$28K 272
2022
Q2
$28K Buy
456
+6
+1% +$371 0.01% 77
2022
Q1
$27K Buy
+450
New +$28.8K 0.01% 86
2021
Q4
Sell
-450
Closed -$31K 157
2021
Q3
$31K Buy
450
+250
+125% +$17.6K 0.01% 65
2021
Q2
$14K Sell
200
-250
-56% -$16.7K ﹤0.01% 59
2021
Q1
$29K Hold
450
0.01% 87
2020
Q4
$26K Buy
+450
New +$27.2K 0.01% 62
2020
Q2
Sell
-506
Closed -$37K 140
2020
Q1
$37K Buy
506
+56
+12% +$3.87K 0.02% 64
2019
Q4
$29K Buy
+450
New +$29.3K 0.03% 79

Other funds holding GILD

TFO Wealth Partners's GILD Position: Q2 2024 in Review

TFO Wealth Partners sold out of Gilead Sciences (GILD) in Q2 2024, closing a stake of 15 shares — an estimated $1.1K sold.

TFO Wealth Partners first reported a position in GILD in Q4 2019 and held it in 14 quarters. The position peaked at $37K in Q1 2020. 1,678 funds tracked by Wall St. Rank hold GILD as of Q2 2024.

  • TFO Wealth Partners reported no remaining Gilead Sciences position as of Q2 2024 after selling out during the quarter.
  • TFO Wealth Partners sold 15 Gilead Sciences shares in Q2 2024, an estimated $1.1K.
  • TFO Wealth Partners first reported a position in Gilead Sciences in Q4 2019 and held it in 14 quarters.
  • TFO Wealth Partners's Gilead Sciences position peaked at $37K in Q1 2020.
  • 1,678 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2024.

Based on TFO Wealth Partners's 13F filing for Q2 2024, filed 15 Aug 2024.